BEAM - Beam Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 9 analysts with an average price target of $46.17. This is a potential upside of $20.94 (83%) from yesterday's end of day stock price of $25.23.

Beam Therapeutics's activity chart (see below) currently has 146 price targets and 134 ratings on display. The stock rating distribution of BEAM is 86.67% BUY and 13.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.16% with an average time for these price targets to be met of 85.41 days.

Highest price target for BEAM is $80, Lowest price target is $26, average price target is $46.17.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 09-Sep-2026. First documented stock forecast 02-Mar-2020.

Best performing analysts who are covering BEAM - Beam Therapeutics:

Bill Maughan David Nierengarten William Pickering Soumit Roy Eric Joseph Gena Wang

Currently out of the existing stock ratings of BEAM, 13 are a BUY (86.67%), 2 are a HOLD (13.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Mar-2020

$65

$40.5 (165.31%)

$65

28 days ago
(09-Sep-2026)

3/9 (33.33%)

$39.82 (158.14%)

154

Buy Since 23-Jul-2024

$80

$55.5 (226.53%)

$80

1 months 12 days ago
(25-Aug-2026)

0/16 (0%)

$48.97 (157.82%)

Buy Since 08-Jul-2026

$47

$22.5 (91.84%)

$47

2 months 22 days ago
(15-Jul-2026)

0/3 (0%)

$16.16 (52.40%)

Buy Since 13-Dec-2022

$68

$33.19 (95.35%)

$56

6 months 11 days ago
(26-Mar-2026)

0/3 (0%)

$44.38 (187.89%)

Hold Since 04-May-2021

$26

$-8.81 (-25.31%)

$20

7 months 12 days ago
(25-Feb-2026)

8/8 (100%)

$-3.61 (-12.19%)

22

Show more analysts

Please expand the browser size to see the chart

What is BEAM (Beam Therapeutics) average time for price targets to be met?

On average it took 85 days for the stock forecasts to be reached, with an average price target met ratio of 42.16%.

Which analyst most recently updated their price target on BEAM (Beam Therapeutics)?

David Nierengarten

Which analyst has the most public recommendations on BEAM (Beam Therapeutics)?

David Nierengarten works at WEDBUSH and has 18 price targets and 12 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics)?

Dae Gon Ha with the highest potential upside of $97.81

Which analyst is the currently most reserved on BEAM (Beam Therapeutics)?

Gena Wang with the lowest potential downside of -$13.81
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?